I figured "one" of the newly approved BP FDA drugs wanted a trial within a trial and had the opportunity to do so after Sunrise stopped due to abnormally high control arm (advised by DMC) where Docetaxel performed like never before...and the BP would get a glimpse of how their newly approved IO drug performed with patients immune systems PRIMED with a PS Targeting drug...
OR was it the Mastermind of Peregrine to give each of them a glimpse of how well it would work, SINCE the opportunity had risen due to the DMC advising to stop the trial ....yet we know now it was due to a broken FDA trial system that even FDA admits..
But hey.....Peregrine may have that leverage now and did Patients live longer ....not meet MOS yet..that were on Bavi PS Targeting before combining so to speak with a new IO approved drug?
Looks like yes and now what other Biomarkers were extracted from Sunrise in combination with their future IO drug???
Nov 8. 2017 we may know.....Epiontis and their new buyer PRECISION FOR MEDICINE KNOWS SOMETHING...is what I saymu
It has been almost 2 years since $PPHM's SUNRISE stop. What has been accomplished since then? Not in any particular order....
(1) More mice petting at world renowned labs by world renowned scientists (2) Infinite dilution leading to the s/p going straight down the toilet (3) Messing up the only source of any revenue - AVID (4) Rascals and their puppets continuing to line their pockets while empoyees get fired (5) Rascals and their puppets continuing to over-promise and never ever delivering (6) Dumpster diving into SUNRISE data to see if there are any hidden nuggets of stone in the crap
Only thing these kings of failure have going for them is that they have plenty of space on the shelf where they can put all their crap with exhibits from the past like Cotara.
Market Data 
Markets 
AI
